PPT-DRUG – DRUG INTERACTIONS

Department of Pharmaceutics 1 26Feb16 Drug interactions These are said to occur when the pharmacological activity of a drug is altered by the concomitant use of another drug or by the presence of some other substance . y.o. male. . Tries to jog 16 km in preparation to join an upcoming marathon.. Ibuprofen. Class: . NSAID (. Propionic. acid derivative) with analgesic and antipyretic properties. Indications: . Symptomatic treatment of arthritis (. Morris Sherman MD . BCh. PhD FRCP(C) . Associate Professor of Medicine. University of Toronto. Protease Inhibitors . in Chronic . Hepatitis C:. An . Update. Chapter 2. – Important Hepatitis C Protease Inhibitor Drug Interactions in Mono and HIV . Duri. . Xixi. Hong. . Joseph . Lustig. Aleksandra . Porebska. . C-. Src. Kinase Inhibition: . A Promising Route in Kidney Cancer Treatment. Outline. Overview of c-. Src. Activation/VEGF pathway. Jennifer N. Fosnot, Pharm.D.. Nurse Practitioners Symposium. Nashville, TN. September 27-28. th. , 2012. Objectives. 1.) Discuss the CYP 450 enzymes and common drug interactions with the immunosuppressants. Presented by:. Dr.Rania. Magadmi. The aim of this presentation is to highlight the clinicalinteractions between herbal product and prescribeddrugs. . . Mechanism of Drug- Herb interactions. Literature review. Louis Wu, PA-C. Presented at VAPAA Annual Meeting. . March 2, 2017. . Financial Disclosures and Conflicts. I have no financial disclosures nor conflicts concerning this talk. . . Learning Objectives. Dr Shaheen. Delivered By . Dr Naser . Drug interactions- objectives. Discuss Pharmacokinetic interactions. List . Pharmacodynamic. interactions. Comment . on common Drug- Food interactions. Drug interactions. Drug-Drug Interactions. Basic mechanisms of drug-drug interactions. Clinical significance of drug-drug interactions. Minimizing adverse drug-drug interactions. Drug-Drug Interactions. Interactions can occur whenever a patient takes more than one drug.. & HCV . Therapy. Larry Pineda, . PharmD. , . PhC. , BCPS, AAHIVP. Visiting Assistant Professor. UNM College of Pharmacy. Conflicts of Interest Disclosure. No conflicts of interest. 2. Learning Objectives – Pharmacist. An Antiretroviral Therapy Review. Sarah Pérez, PharmD, PhC, BCACP, AAHIVP. Disclosure. The speaker has no actual or potential conflicts of interest in relation to this presentation. . Objectives. Pharmacists. Pharmacodynamics. D-R Interact.ions and Pharmacodynamics. Pharmacodynamics. . Describes the actions of drugs on the body and the influence of drug . concentration on the magnitude of the response. Travis R. . Goodwin. 1. , . Dina . Demner-Fushman. 1. , Kin Wah Fung. 1. , . and . Phong. Do. 2. 1. . Lister Hill National Center for Biomedical Communications, . U.S. National Library of Medicine. in . the Management of . HIV: . A Case-Based Discussion. Charles . W. Flexner. , MD. Professor . of Medicine, Pharmacology and Molecular Sciences, and International . Health. The Johns Hopkins University . Drug Drug Interaction Extraction from Product Labels . Bharath . Dandala. (. bdand@us.ibm.com. ). Diwakar Mahajan (. dmahaja@us.ibm.com. ). Ananya Poddar (. poddar@us.ibm.com. ). Introduction. Drug to drug interactions is the most common cause of adverse events, and preventable adverse events are the eighth leading cause of death in the United States..